This statistic shows the projection of the distribution of cost-sharing for generic drugs in the Medicare Part D coverage gap in the United States from 2016 to 2020 . In 2016 , 42 percent of the cost of generic drugs is expected to be paid by CMS . Provisions of the Affordable Care Act mandate the gradual closure of the Medicare Part D coverage gap through pharmaceutical manufacturer discounts and CMS subsidies .
